Physicians from the Intensive Care Medicine Department at Hospital Sant Pau, members of the Sant Pau Research Institute (IR Sant Pau), have participated in the international PROMIZING study. This is one of the most ambitious clinical trials to date aimed at optimizing the discontinuation of mechanical ventilation in patients with severe respiratory failure.
The Sant Pau Research Institute (IR Sant Pau) held its annual Innovation Day 2025 this Tuesday, a flagship event that showcases the talent, creativity, and commitment of the center’s professionals to health innovation. During the event, and as part of the second edition of the INNOPAU program, this year’s winners were announced.
This past weekend, the Born Centre for Culture and Memory was the venue for the 18th Science Festival, a large gathering for all audiences to engage with science and knowledge. The Sant Pau Research Institute (IR Sant Pau) was one of the participating entities, offering three workshops that captivated numerous families.
The Sant Pau Research Institute (IR Sant Pau) presented its new Strategic Plan 2025-2030 this Tuesday, in an event open to all research and healthcare staff. The plan will define the institution’s development lines for the next five years. It focuses on transformative biomedical research, connected to the real needs of society and with a clear international vocation.
Researchers at the Sant Pau Research Institute (IR Sant Pau), in collaboration with the Hospital de Sant Pau and the Josep Carreras Leukaemia Research Institute, have developed an innovative CAR-T cell therapy targeting the CD30 protein (HSP-CAR30). This therapy has shown high efficacy in patients with refractory CD30+ lymphoma.
